Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of K-237 with digoxin and rosuvastatin in healthy volunteers
jRCT2051220054Phase 1Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ursodeoxycholic acid in coronavirus disease 2019 (COVID-19), sponsored by Kowa Company, Ltd. Primary endpoint: Plasma pharmacokinetic parameters of digoxin and rosuvastatin. Started Jul 2022; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2051220054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051220054.